[Venous diseases. Controlled study using an antivaricose preparation Bayro-Vas].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001241:Aspirin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004341:Drug Evaluation; D004928:Escin / Q000627:therapeutic use*; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012503:Saponins / Q000627:therapeutic use*; D014652:Vascular Diseases / Q000188:drug therapy*; D014680:Veins
D004338:Drug Combinations; D004983:Ethanolamines; D012503:Saponins; D004928:Escin; D001241:Aspirin
Venöse Erkrankungen. Eine kontrollierte Studie mit dem Antivarikosum Bayro-Vas